<bill session="114" type="s" number="2512" updated="2018-11-21T21:23:36Z">
  <state datetime="2016-04-19">ENACTED:SIGNED</state>
  <status>
    <unknown datetime="2016-04-19"/>
  </status>
  <introduced datetime="2016-02-08"/>
  <titles>
    <title type="short" as="introduced">Adding Zika Virus to the FDA Priority Review Voucher Program Act</title>
    <title type="short" as="reported to senate">Adding Zika Virus to the FDA Priority Review Voucher Program Act</title>
    <title type="short" as="passed house">Adding Zika Virus to the FDA Priority Review Voucher Program Act</title>
    <title type="short" as="passed senate">Adding Zika Virus to the FDA Priority Review Voucher Program Act</title>
    <title type="short" as="enacted">Adding Zika Virus to the FDA Priority Review Voucher Program Act</title>
    <title type="official" as="introduced">A bill to expand the tropical disease product priority review voucher program to encourage treatments for Zika virus.</title>
    <title type="display">Adding Zika Virus to the FDA Priority Review Voucher Program Act</title>
  </titles>
  <sponsor bioguide_id="F000457"/>
  <cosponsors>
    <cosponsor bioguide_id="A000360" joined="2016-03-15"/>
    <cosponsor bioguide_id="B000944" joined="2016-02-08"/>
    <cosponsor bioguide_id="C001070" joined="2016-02-24"/>
    <cosponsor bioguide_id="I000055" joined="2016-02-08"/>
    <cosponsor bioguide_id="K000360" joined="2016-02-10"/>
    <cosponsor bioguide_id="K000367" joined="2016-03-10"/>
    <cosponsor bioguide_id="M000639" joined="2016-02-10"/>
    <cosponsor bioguide_id="M001169" joined="2016-03-10"/>
    <cosponsor bioguide_id="M001111" joined="2016-03-10"/>
    <cosponsor bioguide_id="N000032" joined="2016-02-08"/>
    <cosponsor bioguide_id="P000449" joined="2016-02-24"/>
  </cosponsors>
  <actions>
    <action datetime="2016-02-08">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2016-02-08" state="REFERRED">
      <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
    </action>
    <calendar datetime="2016-03-09" state="REPORTED">
      <text>Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.</text>
    </calendar>
    <action datetime="2016-03-15">
      <text>Committee on Health, Education, Labor, and Pensions. Reported by Senator Alexander with an amendment in the nature of a substitute. Without written report.</text>
    </action>
    <calendar datetime="2016-03-15" calendar="Senate Legislative" under="General Orders" number="389">
      <text>Placed on Senate Legislative Calendar under General Orders. Calendar No. 389.</text>
    </calendar>
    <vote how="by Unanimous Consent" type="vote" datetime="2016-03-17" where="s" result="pass" state="PASS_OVER:SENATE">
      <text>Passed Senate with an amendment by Unanimous Consent.</text>
      <reference ref="CR S1606-1607" label="consideration"/>
      <reference ref="CR S1606" label="text as passed Senate"/>
    </vote>
    <action datetime="2016-03-18">
      <text>Message on Senate action sent to the House.</text>
    </action>
    <action datetime="2016-03-21T14:15:09-04:00">
      <text>Received in the House.</text>
    </action>
    <action datetime="2016-03-21">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2016-03-25">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2016-04-12T16:32:43-04:00">
      <text>Mrs. Brooks (IN) moved to suspend the rules and pass the bill.</text>
    </action>
    <action datetime="2016-04-12T16:33:01-04:00">
      <text>Considered under suspension of the rules.</text>
      <reference ref="CR H1602-1605" label="consideration"/>
    </action>
    <action datetime="2016-04-12T16:33:54-04:00">
      <text>DEBATE - The House proceeded with forty minutes of debate on S. 2512.</text>
    </action>
    <vote how="by voice vote" type="vote2" datetime="2016-04-12T16:46:45-04:00" where="h" result="pass" state="PASSED:BILL">
      <text>On motion to suspend the rules and pass the bill Agreed to by voice vote.</text>
      <reference ref="CR H1602" label="text"/>
    </vote>
    <action datetime="2016-04-12T16:46:52-04:00">
      <text>Motion to reconsider laid on the table Agreed to without objection.</text>
    </action>
    <topresident datetime="2016-04-14">
      <text>Presented to President.</text>
    </topresident>
    <signed datetime="2016-04-19" state="ENACTED:SIGNED">
      <text>Signed by President.</text>
    </signed>
    <enacted number="114-146" type="public" datetime="2016-04-19">
      <text>Became Public Law No: 114-146.</text>
    </enacted>
  </actions>
  <committees>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Referral"/>
    <committee subcommittee="Health" code="HSIF14" name="House Energy and Commerce" activity="Referral"/>
    <committee subcommittee="" code="SSHR" name="Senate Health, Education, Labor, and Pensions" activity="Reporting, Markup, Referral"/>
  </committees>
  <relatedbills>
    <bill type="h" session="114" relation="identical" number="4400"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Drug therapy"/>
    <term name="Infectious and parasitic diseases"/>
  </subjects>
  <amendments/>
  <summary date="2016-04-20T03:59:59Z" status="Public Law">(This measure has not been amended since it was reported to the Senate on March 15, 2016. The summary of that version is repeated here.)

Adding Zika Virus to the FDA Priority Review Voucher Program Act

(Sec. 2) This bill amends the Federal Food, Drug, and Cosmetic Act to add Zika virus disease to the list of tropical diseases under the priority review voucher program, which awards a voucher to the sponsor of a new drug or biological product that is approved to prevent or treat a tropical disease. (A voucher entitles the holder to have a future new drug or biological product application acted upon by the Food and Drug Administration within six months.)

The bill makes a technical correction to the tropical disease list to refer to filovirus disease, a condition caused by the family of viruses that includes the Ebola virus, instead of the family of viruses.</summary>
  <committee-reports/>
</bill>
